Tocagen (TOCA), NRG Oncology Announce Collaboration on Phase 2/3 Trial of Toca 511 & Toca FC in Newly Diagnosed Glioblastoma

November 29, 2018 8:02 AM

Tocagen Inc. (NASDAQ: TOCA) today announced that the NCI Cancer Therapy and Evaluation Program (CTEP) Brain Malignancies Steering Committee has ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found